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Individual differences in cognitive decline during normal aging and Alzheimer’s disease (AD) are common, but the molec-
ular mechanisms underlying these distinct outcomes are not fully understood. We utilized a combination of genetic, mo-
lecular, and behavioral data from a mouse population designed to model human variation in cognitive outcomes to search
for the molecular mechanisms behind this population-wide variation. Specifically, we used a systems genetics approach to
relate gene expression to cognitive outcomes during AD and normal aging. Statistical causal-inference Bayesian modeling
was used to model systematic genetic perturbations matched with cognitive data that identified astrocyte and microglia mo-
lecular networks as drivers of cognitive resilience to AD. Using genetic mapping, we identified Fgf2 as a potential regulator
of the astrocyte network associated with individual differences in short-term memory. We also identified several immune
genes as regulators of a microglia network associated with individual differences in long-term memory, which was partly
mediated by amyloid burden. Finally, significant overlap between mouse and two different human coexpression networks
provided strong evidence of translational relevance for the genetically diverse AD-BXD panel as a model of late-onset AD.
Together, this work identified two candidate molecular pathways enriched for microglia and astrocyte genes that serve as
causal AD cognitive biomarkers, and provided a greater understanding of processes that modulate individual and popula-
tion-wide differences in cognitive outcomes during AD.
[Supplemental material is available for this article.]
Alzheimer’s disease (AD) dementia is a common neurodegenera-
tive disorder defined by extracellular amyloid plaques and intracel-
lular neurofibrillary tangles, and characterized by progressive
memory decline (Selkoe 1991). Many of the tested therapies for
AD have focused on targeting and clearing pathological
beta-amyloid (Aβ), which has been extensively researched as an
initiating factor that leads to neurodegeneration and cognitive
impairment (Hardy and Selkoe 2002; Selkoe and Hardy 2016). To
date, therapeutics to delay or reverse the progression of
AD-related cognitive decline have been disappointing, despite sig-
nificantly removing Aβ burden (Gao et al. 2016; Elmaleh et al.
2019). These drug failures, and investigations into the origin of
AD more broadly, are both impacted by the divergence between
the clinical (cognitive decline) and pathological (amyloidosis and
hyperphosphorylated tau) presentation of the disease, with some
cognitively intact elderly individuals exhibiting significant amy-
loidosis consistent with new diagnostic criteria for AD (Morris
et al. 1996; Budson and Solomon 2012; Negash et al. 2013). Even
individuals with well-defined familial AD (FAD) mutations in am-
yloid precursor protein (APP) or presenilin 1 (PSEN1) genes can
maintain cognitive function well beyond their sixth decade, de-
spite robust amyloid and tau pathological burden, identifying indi-
viduals that are resilient to pathology-induced cognitive decline
(Crystal et al. 1988; Katzman et al. 1988; Ryman et al. 2014;
Arenaza-Urquijo and Vemuri 2018). In light of this disconnect be-
tween AD pathology and cognitive symptoms, there is a critical
need to understand how genetic background can modify the im-
pact of amyloid on variation in AD cognitive decline.
Recent advances in genomic techniques have enabled de-
tailed investigation of cognitive decline using genome-wide tran-
scriptional profiling from postmortem brains of demented and
nondemented control individuals (Miller et al. 2013; Zhang et al.
2013; Narayanan et al. 2014; De Jager et al. 2018). Although these
studies have identified someof the processes associatedwith cogni-
tive decline, such as increased brain inflammation and neurode-
generative pathways, there is still an incomplete understanding
of the factors that directly drive cognitive outcomes in dementia
patients. One recent study used an integrative approach which
combined postmortem gene coexpression, measures of cognitive
decline, and measures of pathology to generate a Bayesian
conditional-dependency network that identified several modules
predicted to directly influence cognitive decline without patholo-
gy (Mostafavi et al. 2018). This was a key development in under-
standing the complex etiology of AD-related cognitive decline in
that rather than identifying correlational relations, this study
used Bayesian directed modeling that incorporated molecular net-
works, pathological, and cognitive measures to propose a candi-
date biological network that directly influenced cognitive decline
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without the direct influence of pathology. However, the reliance
on postmortem tissues limits our ability to define early molecular
changes that may drive onset of dementia, especially since many
of these processes start long before the onset of cognitive symp-
toms (Fox et al. 1996; Paterson et al. 2014; Hohman et al. 2017).
To identify novel genetic factors and molecular systems that
are responsible for resilience to cognitive symptoms of AD longitu-
dinally and under controlled environmental conditions, we sys-
tematically examined the effect of FAD mutations on cognitive
traits in a genetically diverse panel of mice; the AD-BXDs
(Neuner et al. 2019a). The AD-BXDgenetically diversemousemod-
el of AD incorporates the commonly used 5XFAD transgene across
a number of diverse, yet inbred,mouse strains from the BXDgenet-
ic reference panel (Neuner et al. 2019a). We found that the
AD-BXDs exhibited variation in cognitive decline similar to that
observed in human FAD populations (Ryman et al. 2014). This var-
iation was sensitive to genetic risk factors associated with human
sporadic AD (Neuner et al. 2019a), sug-
gesting this is a translationally relevant
model of late-onset AD (LOAD).
The goal of this study is to build on
our previous findings to further prioritize
the molecular systems which likely ac-
count for the wide range of cognitive
outcomes using a population of identi-
cal individuals with and without AD
mutations. We took a systems biology
approach combining genetic, transcrip-
tomic, and behavioral data from a large
population of normal aging (Ntg-BXD)
and AD (AD-BXD) cases (Fig. 1). Specifi-
cally, we inferred gene coexpressionmod-
ules from hippocampus transcriptome
data of a genetically diverse mouse popu-
lation from young [6 mo old (6 mo)] and
aged [14 mo old (14 mo)] individuals.
Each of these modules represents the ac-
tivity of one or more molecular systems,
and was identified in a purely data-driven
manner, blind to genotype or behavioral
outcomes. Then, we identified which
modules and molecular systems were as-
sociated with age, amyloid mutations,
and cognitive outcomes. Genetic map-
ping of module eigengene expression as
quantitative traits identified genetic re-
gions that regulated each module. We
then used Bayesian conditional depend-
encymodeling (Tasaki et al. 2015) to elim-
inate redundant associations and predict
the subset of modules driving individual
differences in cognition across the popu-
lation, and calculated if these relations
were dependent on the presence of
amyloid-driving mutations, and if mod-
ule–trait relations were strengthened by
the addition of cortical amyloid burden
into our statistical model. Finally, we test-
ed if the prioritized molecular networks
from this study are translationally rele-
vant by testing the overlap between
mouse and human dementia networks
(Bennett et al. 2012; Mostafavi et al.
2018; Wan et al. 2020). This approach
nominates robust molecular systems that
consistently relate to individual differenc-
es in cognition in an aging and AD populations, and evaluates the
effect of these systems on cognitive outcomes. Furthermore, addi-
tional modeling that incorporated cortical Aβ1-42 ELISA suggests
an indirect relation of AD pathological burden on cognitive out-
comes in promoting differences in molecular network activity,
and highlights the utility of mouse models for discovering several
molecular systems to monitor for resilience and manipulate them
in future validation studies to improve AD cognitive outcomes.
Results
Defined molecular systems of the hippocampus in AD-BXD
and Ntg-BXD mice
In order to identify the molecular systems associated with cogni-
tive outcomes across the population of both AD and non-AD




Figure 1. Genetically diverse mice can be leveraged to understand the relevant molecular networks
that underlie individual differences in cognitive outcomes. Schematic of SpeakEasy module formation
and relation to cognitive outcomes, adapted from Mostafavi et al. (2018). (A) Multiple strains of genet-
ically diverse mice that are carriers (AD-BXD) or noncarriers (Ntg-BXDs) for the 5XFAD transgene (FAD
mutations) are combined to generate a population with genetic diversity similar to what is observed in
humans. These strains make up a genetic reference panel, allowing for the incorporation of genetic in-
formation into further analyses. Each mouse is brought through a cognitive phenotyping pipeline (de-
scribed in Neuner et al. 2019a), taking measures for working memory, short-term memory, and
long-term memory at 6 mo or 14 mo of age, and harvest of hippocampal tissue for downstream anal-
yses. (B) Measures of the three cognitive domains taken during the phenotyping pipeline are assessed
from AD-BXD and Ntg-BXD mice at 6 mo and 14 mo of age (left), while gene coexpression modules
are separately formed from the same mice using SpeakEasy consensus clustering (middle).
Additionally, genetic information is obtained from each strain for downstream genetic mapping and in-
tegration into the module-trait network (right). (C) Gene expression modules are related to cognitive
traits using Spearman correlations, and modules significantly (adj. P<0.05) correlated to at least one
cognitivemeasure are selected for downstream analysis. These cognitively relevantmodules are integrat-
ed with cognitive measures, and anchored by BXD genetics to form a module-trait Bayesian directed
network, and modules directly upstream of cognitive traits are prioritized for further characterization.
(D) Cognitively relevant modules are compared with human brain modules to investigate gene–gene
conservation between mouse and human.
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from the hippocampus of AD-BXDandNtg-BXDmice at either 6 or
14 mo of age (n=294) (Neuner et al. 2019a,b). Biological replicates
from the strain, sex, and genotype groups were averaged together,
generating a total of 156 unique group-averaged measures.
With these data, we then performed unsupervised consensus clus-
tering and identified 28 discrete transcriptional modules of >29
genes, ranging in membership size from 42 to 1419 transcripts
(Supplemental Table S1). We commonly refer to these modules
as gene sets, but recognize that in this context we more formally
mean sets of mRNAs with one-to-one relations to genes. We chose
the SpeakEasy consensus clustering algorithm over other cluster-
ing algorithms, such as weighted gene coexpression network anal-
ysis (WGCNA), because it is less parameter-driven and carries a
higher degree of run-to-run stability for transcriptome network
conservation (Gaiteri et al. 2015; Mostafavi et al. 2018). To gain a
basic understanding of the biological processes and cell-types en-
riched in each module, we performed gene ontology (GO) biolog-
ical process enrichment on each module (Supplemental Table S2),
as well as cell-type enrichment using a well-established and mine-
able RNA-seq data set from mouse cortex (Zhang et al. 2014). The
major molecular functions and module–module relations of these
gene sets are highlighted in Figure 2. Modules that were clustered
together based on covariation in expression are also similarly char-
acterized based on cell-type and biological function, without hav-
ing overlapping members since each module was formed using
discrete gene assignment. These included a group of modules en-
riched for genes expressed in neurons, as well as synaptic organiza-
tion and intracellular transport GO terms, a large grouping of
astrocyte modules enriched for RNA processing, cell movement,
and chromatin remodeling GO terms, a mixed endothelial cell
and astrocyte grouping of modules enriched for metabolism GO
terms, and a microglia module group enriched for immune func-
tion GO terms (Fig. 2). The annotation of these covarying molecu-
lar systems identifies the major cell-types and biological pathways
present in the hippocampus of our population, a subset of which
may change as a function of aging and/or disease processes.
Prioritizing molecular systems related to cognitive
outcomes highlights immune and metabolic networks
The coexpression analysis described above defined the basicmolec-
ular systems that can be robustly identified and evaluated inmouse
hippocampi. Importantly, these mRNA sets are formed without
any reference to genotype or phenotype. Therefore, we next con-
sidered how the average expression of each coexpression module
was related to sex, age, and FAD mutation carrier status
Figure 2. AD-BXD and Ntg-BXD have variable transcriptional networks across aging and Alzheimer’s individuals. SpeakEasy consensus clustering iden-
tified 31 discrete transcriptional modules from hippocampal RNA sequencing of Ntg/AD-BXD mice (n=26 strains). Modules containing <30 genes were
excluded (n=3 modules). Average module expression per sample was derived using average standardized gene expression of module members. Modules
were correlated to each other (Pearson) and hierarchically clustered. Cell-type enrichment was performed on the genes within each module using the
Zhang et al. (2014) data set to obtain an idea of represented cell-types for each module. Cell-type enrichments were performed using hypergeometric
tests to identify significant relationships (adj. P<0.05) for astrocytes, endothelial cells (EC), neurons, microglia, oligodendrocyte precursor cells (OPC),
new oligodendrocytes (New Oligo.), and myelinating oligodendrocytes (Myelin. Oligo.). GO enrichment was performed on the genes in each module,
and the GO term most significantly enriched within a module is denoted (NS GO=no significant GO enrichment).
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(Supplemental Figs. S1–S3), and cognitive status (Fig. 2). To do this,
we first generated a summary statistic for each module by calculat-
ing the average standardized expression of the gene members for
each module. Next, we compared each module summary statistic
with strain-averaged performance on cognitive tasks using
Spearman correlation analysis. These tasks spanned multiple cog-
nitive domains and included working memory using spontaneous
alternation on the Y-maze and acquisition and recall of contextual
fear conditioning at both 6 and 14mo of age. Spontaneous alterna-
tion relies on a rodent’s innate tendency to explore novel environ-
ments while avoiding familiar environments and assesses
hippocampal- and cortical-dependent spatial working memory.
This task was initially chosen due to the lack of need for training,
reward, or punishment, and the ability to testmice on this task lon-
gitudinally (Holcomb et al. 1998; Ohno et al. 2004; Oakley et al.
2006). Contextual fear conditioning enables the assessment of
both hippocampal-dependent short-term memory during the
acquisition phase in which mice are administered four mild
foot shocks (Chen et al. 1996; Neuner et al. 2015), as well as
hippocampal-dependent spatial orientation, recall, and long-term
memory during the testing phase in which mice are placed back
into the training chamber in the absence of foot shocks 24 h after
contextual fear conditioning training (Kim and Jung 2006; Neuner
et al. 2015).
We identified 16modules that significantly correlated with at
least one cognitive outcome (Fig. 3A; Spearman, adj. P<0.05).
There were 6modules (5 negative, 1 positive) significantly correlat-
ed with percent successful spontaneous alternations (%SA) on the
Y-maze working memory task. The modules negatively correlated
with %SA on the Y-maze working memory task (m2, m4, m6,
m7, m8) contain genes highly expressed in microglia, and en-
riched for GO biological processes including cell migration, im-
mune function, and lipid biosynthesis processes. The only
module positively correlated with %SA on Y-maze (m20) con-
tained members that are also expressed in microglia and were en-
riched for noncoding RNA processing GO terms. There were 16
modules (8 negative, 8 positive) that significantly correlated with
contextual fear acquisition (CFA) slope (see Materials and Meth-
ods). The negatively correlatedmodules contained genes expressed
in astrocytes and microglia and were primarily enriched for GO
terms associated with immune function (m4, m5, m6) as well as
cell migration (m1, m2, m3) and lipid biosynthesis and metabo-
lism (m7, m8). The positively correlated modules contained genes
expressed primarily in neurons andwere enriched for GOprocesses
associated with synaptic signaling and organization (m13, m15,
m16, m23, m28), mitochondrial transport (m18), and RNA
processing and metabolism (m14, m20). Finally, there were 6
modules (5 negative, 1 positive) significantly correlated with con-
textual fear memory (CFM). The negatively correlated modules
contained genes expressed inmicroglia and astrocytes andwere en-
riched formigration (m2), immune (m4,m5,m6) and lipid biosyn-
thesis (m7) processes. The positively correlated module (m14) was
enriched for genes associated with purine
metabolism processes and contained
genes expressed in multiple cell-types in-
cluding endothelial cells, neurons, micro-
glia, and myelinating oligodendrocytes.
One thing to note is that we identified
four modules that were significantly cor-
related with all three cognitive outcomes
(m2, m4, m6, m7), suggesting perturba-
tion of these modules would influence
all three cognitive domains, instead of
being-domain specific processes. Togeth-
er, results from these analyses suggest
that increased number of transcripts asso-
ciated with antiviral and innate immune
pathways inmicroglia, as well as lipid bio-
synthesis pathways in astrocytes associate
with lower cognitive performance, while
synaptic signaling and purine metabo-
lism pathways that are enriched in neu-
ron and oligodendrocyte precursor cells
are associated with higher cognitive per-
formance, highlighting these biological
networks as resilience candidates.
In addition to identifying significant
module–trait relations, we also tested the
extent to which significantly correlated
modules explained variance in cognitive
outcomes across the population. Initially,
we calculated heritability of each trait to
determine the amount of variance genet-
ic background (or BXD strain) explained
for each cognitive outcome. Similar to
our previous findings (Neuner et al.
2019a), the majority of the variance in
cognitive outcomes could be explained
by genetic background, with 73% herita-
bility for %SA on Y-maze workingmemo-
ry, 70% heritability for CFA slope, and





Figure 3. Correlation analysis reveals a select sixteen modules related to cognitive outcomes.
(A) Average standardized module expression was correlated to cognitive traits to identify modules
that may significantly modify cognitive function. Modules significantly (Spearman, adj. P<0.05) corre-
lated to measures of working, short-term, and long-term memory are highlighted above. (B–D) The pro-
portion of variance in measures for working memory (B), short-term memory (C), and long-term
memory (D) explained by individual module average expression. Bars are colored based on directionality
of correlation to cognitive measure, with positive correlations in blue and negative correlations in red. All
modules are denoted by the most significantly enriched GO term (NS GO=no significant GO
enrichment).
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way ANOVA analyses we separately calculated the amount of vari-
ance in each cognitive outcome that could be explained by binary-
coded variables such as age, sex and presence of FAD mutations
(Supplemental Table S3). Age was the only variable that signifi-
cantly affected %SA on Y-maze working memory, explaining
8.2% of the variance in %SA. Additionally, age was the only vari-
able explaining significant variance for CFM, explaining 12.7%
of the variance in %freezing on this task. Finally, age and FADmu-
tation carrier status explained significant variance for CFA slope,
with 4.6% explained by age, and 19.9% explained by FAD muta-
tion carrier status.
Using linear regression modeling, the variance of each cogni-
tive outcome explained by module expression was calculated and
used as a proxy for effect size of module expression on cognitive
outcomes. We focused only on module–trait relationships that
reached statistical significance in our Spearman correlation analy-
sis, and performed individual linear regressions for each module–
trait pair. The modules that explained the most variance for work-
ingmemory (%SA) outcomeswere the epithelialmigrationmodule
(m2, 5.6%), lipid biosynthesis module (m7, 5.8%) and coenzyme
metabolism module (m8, 5.7%) (Fig. 3B). Variance in CFA short-
termmemory outcomeswas explainedmore strongly and by a larg-
er number ofmodules than%SA, including immunemodules (m4,
24.0%; m5, 16.0%, m6, 21.3%), and the lipid biosynthesis module
(m7, 27.8%) (Fig. 3C). The modules that explained the greatest
amount of variance for CFM long-term memory outcomes includ-
ed the immune: virusmodule (m5, 10.5%), lipid biosynthesismod-
ule (m7, 9.3%), and purine metabolism module (m14, 7.7%) (Fig.
3D).While thesemodule-trait correlations can prioritizemolecular
systems in disease, the causal nature of these relationships is un-
clear. Therefore, we proceeded to integrate genetic priors and con-
ditional dependences to further assess the robustness of the top
findings from these initial results.
Genetic network analysis supports a role for lipid
biosynthesis and viral immune enriched molecular
networks in cognitive resilience
As the effect of a molecular system on a phenotype may be condi-
tional on activation of other molecular systems, we tested for such
relations in the module-trait associations we identified. In this
analysis, we simultaneously utilized module expression for the
16 cognitive relevantmodules, cognitivemeasures, as well as infor-
mation about genomic regions involved in regulating module ex-
pression. Chromosomal regions that regulate module expression
were identified using genetic mapping in which module eigen-
genes were used as quantitative traits. According to the central
dogma of expression genetics (Crick 1958; Williams et al. 2007),
DNA variants influence RNA expression, which then modulates
downstream behavioral phenotypes such as cognitive outcomes
(Hsu et al. 2007). As such these chromosomal regions were used
as causal anchor points in our Bayesian network analysis to at-
tempt to identifywhichmolecular networks (and chromosomal re-
gions) were causally associated with cognitive outcomes. The
modules predicted to directly influence cognitive outcomes were
m7 (astrocytes, lipid biosynthesis) for Y-maze working memory
and CFA short-term memory and m5 (microglia, immune: virus)
for CFM long-term memory (Fig. 4).
The module directly upstream of Y-maze working memory
andCFA short-termmemory,m7, also explained themost variance
in these cognitive measures (Fig. 3B,C). Module m7 contained 243
genemembers,making it smaller in size in comparison to the three
majormicrogliamodules with 1088members inm4, 848members
in m5, and 681 members in m6. This module was most signifi-
cantly enriched for GO terms related to lipid biosynthesis and for
genes that are highly expressed in astrocytes (Fig. 2). Ingenuity
pathway analysis (IPA) identified multiple molecular systems en-
riched in this gene set consistent with astrocyte activity including
Interleukin-1 (IL-1) signaling, cholesterol biosynthesis and actin
cytoskeleton signaling (Table 1). Specifically, the m7 genes en-
riched in the IL-1 signaling pathway were Irak2 and Irak3, part of
the IRAK family of proteins that are involved in direct downstream
signaling of the IL-1 receptor, as well asRhoa,which is important to
actin cytoskeleton signaling.
The module directly upstream of CFM long-term memory
outcomes was m5, enriched for GO biological processes associated
with viral immune response (Fig. 2). This module consisted of 848
genemembers,making it one of the largestmodules constructed in
this analysis. Enrichment of thismodule for GO biological process-
es and IPA canonical pathways highlighted the primary function
of this module was proinflammatory immune signaling.
Specifically, many of the enriched IPA canonical pathways refer-
enced pathways involved in immune responses to virus, such as
“role of pattern recognition receptors in recognition of bacteria
and viruses,” “interferon signaling,” and “acute phase response
signaling” (Table 2), confirming the primary function of this mod-
ule as immune response. Upon further inspection ofmodulemem-
bers that also participated in these pathways, many aremembers of
the interferon response pathway (e.g., Oas1, Oas1b, Oas2, Oas3,
Eif2ak2, and Ifih1) which is the primary pathwayactivated uponvi-
ral infection (Kawai and Akira 2006, 2007).
Figure 4. Bayesian conditional dependency modeling of cognitively rel-
evant modules and traits defines causal module–trait relationships.
Genetics (green triangles), module expression (blue circles, denoted by
most significantly enriched GO term), and measures for each cognitive
domain (red diamonds) were combined into a single module-trait
network using Bayesian conditional dependency modeling. The
genomic priors used in this analysis were the identified genetic regions as-
sociated with module eigengenes (PC1), and the chromosome(s) that
each region mapped to is denoted inside each triangle. The thickness of
the arrows represents the number of times a module–module or
module–trait relationship was detected.
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Genetic mapping of m7 module eigengene identifies
Fgf2 as a regulator of m7 and short-term memory
outcomes
Amajor advantage of using genetic reference panels tomodel poly-
genetic disorders is the ability to perform genetic mapping of com-
plex traits for such disorders, including measures of module
expression, to identify chromosomal regions and genes within
them that regulate these traits. To identify chromosomal regions
regulating module expression we performed quantitative trait
loci (QTL)mapping ofmodule eigengenes for all cognitive relevant
modules (Fig. 4; Supplemental Table S4, depicted as green trian-
gles). Specifically, we focused on identifying chromosomal regions
regulating m5 and m7 expression, since these modules were iden-
tified through Bayesian modeling as being directly upstream of
cognitive outcomes. While we did not identify any QTLs for the
m5 eigengene, we identified a significant QTL for the m7 eigen-
gene, which fell in a small region on chromosome 3 (36.5–53.3
Mb), which means genetic variation within this region corre-
sponds to variation in m7 expression (Fig. 5A). Within this region
of chromosome 3 we identified 45 protein coding genes, only one
of which was a member of m7, Fibroblast growth Factor 2 (Fgf2),
identifying this gene as a possible regulator of m7 expression and
activity. Investigation of the variants in Fgf2 between C57BL/6J
and DBA2/J in the Sanger Mouse Genomes database highlighted
many single nucleotide polymorphisms (SNPs) between the two
strains, the most notable being a possible splice donor and/or mis-
sense variant (Keane et al. 2011). Additionally, our data show that
hippocampal Fgf2 expression is significantly higher in strains that
carry the B allele compared to strains that carry the D allele at the
marker SNP closest to the Fgf2 gene body (Fig. 5B). Finally, we
found that Fgf2 expression significantly negatively correlated
with Y-maze working memory outcomes in strains that carried
the B allele at Fgf2, but carried no significant relationship with
mice that carried the D allele at Fgf2 (Fig. 5C). Comparatively,
Fgf2 expression in all strains significantly negatively correlated
with CFA short-term memory outcomes (Fig. 5D). Together, this
genetic mapping nominated a candidate by which m7 expression
and possibly activity is controlled, and further experiments will
determine the exact role by which Fgf2 may control memory out-
comes during aging and AD.
Molecular subnetworks for m5 implicate specific immune
pathways and genes as modulators of long-term memory
outcomes
Since a large number of genes (848 genes) fell into m5, the module
directly upstream of CFM long-term memory outcomes in the
Bayesian network, we conducted a subclustering analyses to re-
solve smaller molecular networks that may exist within the larger
module. Specifically, we performed SpeakEasy clustering analysis
on gene expression measures from m5 members, and identified
five distinct subclusters (SCs) within m5 (Fig. 6A; Supplemental
Table S5). GO enrichment of the geneswithin each SC revealed im-
munological pathways as the top enriched GO term, such as re-
sponse to virus (SC1), lymphocyte differentiation (SC2), acute
inflammation (SC3), Interleukin-8 (IL-8) secretion (SC4), and acro-
some reaction (SC5) (all enriched GO terms in Supplemental Table
S6). Spearman correlation of each SC to CFA slope short-term
memory and CFM long-term memory outcomes highlighted sig-
nificant negative module-trait correlations for each SC except for
SC5, which was only correlated with long-termmemory outcomes
(Fig. 6B). Furthermore, SC1: response to virus, SC3: acute inflam-
mation and SC4: IL-8 secretion explained comparable variance in
CFA slope short-term memory outcomes to m5 expression (Fig.
6C), while SC3 and SC4 explained comparable variance in long-
term memory outcomes to m5 expression (Fig. 6D). Finally, while
the m5 eigengene alone did not map to a QTL, we identified six
QTLs for the SC5 eigengene (Fig. 6E; Supplemental Table S4).
The m5 gene members within these regions were enriched for im-
mune functions, suggesting regions of the genome that contain
genes associated with immune function could also be important
for regulating how m5 controls long-term memory outcomes,
since SC5 was also correlated with long-term memory.
Furthermore, when we investigated how m5 SCs were genetically
controlled in the AD-BXD population, we found that the SC5
eigengenemapped to a smaller region on chromosome 1 that over-
lapped with the QTL we identified in Figure 6E (Supplemental Fig.
S5C; Supplemental Table S4). This region of chromosome 1 was
also enriched for m5 members associated with the interferon re-
sponse pathway (Ifi204, Ifi202b), adaptive immune response
(Exo1, Fcrl6) and glia signaling (Kcnj10) (Supplemental Fig. S5D).
Together, this subclustering analysis further elucidates the overall
Table 2. Top five IPA enriched canonical pathways for module 5 (m5, immune: virus)
IPA canonical pathway P-value Genes
Role of pattern recognition receptors in
recognition of bacteria and viruses
3.98 ×10−12 C3, Ccl5, Cntf, Ddx58, Eif2ak2, Faslg, Ifih1, Il18, Il1a, Il21, Irf7, Ltb, Myd88, Nod2,
Oas1, Oas1b, Oas2, Oas3, Ptx3, Tlr3, Tlr6, Tnf, Tnfsf10, Tnfsf12
Systemic lupus erythematosus in B cell
signaling pathway
1.00 ×10−10 Cd72, Cd79a, Cd79b, Cntf, Faslg, Ifih1, Ifit2, Ifit3, Ighm, Il18, Il1a, Il21, Irf7, Irf9, Isg15,
Isg20, Lilrb3, Ltb, Myc, Myd88, Pik3ap1, Rras, Shc1, Stat1, Stat2, Tlr3, Tnf, Tnfsf10,
Tnfsf12, Traf1
Interferon (IFN) signaling 1.62 ×10−9 Ifi35, Ifit3, Ifitm3, Irf1, Irf9, Isg15, Oas1, Socs1, Stat1, Stat2, Tap1
Th1 and Th2 activation pathway 8.32 ×10−9 Acvr1c, Aph1a, Cd274, Cd28, Cd3d, Cd3e, Cd3g, Cd8a, Cxcr6, Icam1, Icos, Il18, Il2rb,
Irf1, Jak3, Klrd1, Socs1, Socs3, Stat1, Stat4, Stat6
Acute phase response signaling 1.70 ×10−8 A2m, C1r, C1s, C3, Hpx, Il18, Il1a, Il1rn, Itih3, Map2k3, Myd88, Rras, Serpina3,
Serpinf1, Serpinf2, Serping1, Shc1, Socs1, Socs3, Tnf, Tnfrsf11b
Table 1. Top Five IPA enriched canonical pathways for module 7 (m7, lipid biosynthesis)
IPA canonical pathway P-value Genes
Role of macrophages, fibroblasts and endothelial cells in
rheumatoid arthritis
3.89 × 10−6 Cebpg, Fgf2, Fzd9, Il17ra, Il33, Irak2, Irak3, Nfkbie, Plce1, Rap1b, Rhoa,
Ripk1, Stat3, Tcf7l1
Superpathway of cholesterol biosynthesis 8.13 × 10−6 Dhcr24, Dhcr7, Hmgcs1, Hsd17b7, Idi1
Interleukin-1 (IL-1) signaling 3.89 × 10−5 Gna12, Gna13, Gng12, Irak2, Irak3, Nfkb2, Nfkbie
Actin cytoskeleton signaling 8.32 × 10−5 Cyfip1, Fgd3, Fgf2, Gna12, Gna13, Gng12, Gsn, Rap1b, Rhoa, Wasf2
Regulation of the epithelial-mesenchymal transition pathway 1.58 × 10−4 Fgf2, Fgfrl1, Fzd9, Hgf, Nfkb2, Rap1b, Rhoa, Stat3, Tcf7l1
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function of m5 for viral and adaptive immune response, and nom-
inates a region on chromosome 1 that could be important for con-
trolling m5 expression. Future experiments will deduce the
function of this genetic region, and how genes withinmay control
m5 expression and possibly long-term memory outcomes.
The effect of module expression on AD-BXD long-term
memory outcomes is partially modulated by amyloid
accumulation
While the previous analyses were performed on the combined
AD-BXD and Ntg-BXD population that contained individual
strains that did not carry amyloid-driving mutations, many of
the networks explaining large variance in cognition, such as in-
flammation (m4 andm5), related to pathways previously implicat-
ed in the etiology of AD. To evaluate how the presence of the
5XFAD transgene affected module expression, we used three-way
ANOVA tests on module expression, and found that 11 of the 16
cognitively relevant modules were significantly affected (adj. P<
0.05) by presence of the 5XFAD transgene (Supplemental Fig.
S1), suggesting that the presence of amyloid-driving mutations ac-
counts for the majority of the significant module-–trait relation-
ships. To test if module–trait relationships were primarily driven
by the presence of FAD mutations, we recalculated the module–
trait Spearman correlations of the 16 cognitively relevant modules
for the Ntg-BXD and AD-BXD populations separately. While there
were no significant module-trait correlations in the Ntg-BXD pop-
ulation, we found that 7 of the 16 original cognitively relevant
modules continued to be correlated to cognitive outcomes in the
AD-BXD population, including m5 (immune: virus) and m7 (lipid
biosynthesis), which were the modules directly upstream of cogni-
tive outcomes in the Bayesian model (Fig. 7A; Supplemental Table
S7). This supported the hypothesis that the presence of amyloid-
driving mutations strengthens the module-–trait relationships
that explain a portion of the individual differences in cognitive
outcomes.
To determine the degree to which the seven significant mod-
ule–trait relationships within the AD-BXD population were depen-
dent on the amount of brain amyloid (Fig. 7A), we quantified the
amount of variance that cortical amyloid load explained for each
cognitive measure within the AD-BXD population (Aβ1-42 ELISA
assay previously reported in (Neuner et al. 2019a)). Cortical
Aβ1-42 (ng/mg total protein) explained 3.5% of working memory
(not statistically significant), 9.0% of short-term memory (P<
0.05), and 14.3% of long-term memory outcomes (P<0.01) (Fig.
7B). For several modules Aβ1-42 could explain a large amount of
the variance in module expression, such as 29.4% of the variance
in m4 expression, and 26.3% of the variance in m7 expression (P
<0.01) (Fig. 7C). This suggested that Aβ1-42 likely influences the
expression of modules within AD-BXDs.
To test the degree to which cortical Aβ1-42 modulated the ef-
fect of each module (as measured by average expression) had on
each cognitive domain, we generated linearmodels for each signif-
icant module–trait relationship, with the addition of cortical
Aβ1-42 ELISA measures as a second independent variable within




Figure 5. Mapping of the module upstream of working memory and short-term memory measures identifies Fgf2 as a potential driver. (A) Genetic
mapping of m7 using the first principal component (PC1) as module eigengene. Age, sex, and FAD mutation status were used as additive covariates.
(B) Stratification of Fgf2 expression based on genotype at the closest marker single nucleotide polymorphism (SNP) to Fgf2 genetic location (Student’s
t-test, P<0.05). (C) Fgf2 expression is significantly correlated (Spearman, P<0.05) with overall working memory performance only in mice with the
B/B genotype at the marker SNP closest to Fgf2 but not with B/D. (D) Fgf2 expression is significantly correlated (Spearman, P<0.05) with overall short-term
memory performance in mice with either the B/B or and B/D genotype at the marker SNP closest to Fgf2. Significant correlations denoted by red asterisks.
NS=no significant correlation.
Molecular systems of cognitive resilience
www.learnmem.org 361 Learning & Memory
 Cold Spring Harbor Laboratory Press on August 24, 2020 - Published by learnmem.cshlp.orgDownloaded from 
significant module-Aβ1-42 interactive effects on cognitive out-
comes that identified only one module-Aβ1-42 relationship (m4)
had a significant interactive effect on Y-maze %SA (Supplemental
Table S8). Since only a single interactive effect was obtained, we
tested the additive effect of module expression and cortical
Aβ1-42 accumulation using Type 2 ANOVA statistical tests
(Supplemental Table S8), as well as likelihood-ratio (LRT) tests to
determine if the addition of amyloid into the model significantly
improved the linear fit that explained cognitive outcomes using
module expression (Satorra and Saris 1985). Within AD-BXD indi-
viduals, module expression for each significantly correlated mod-
ule explained up to 10% of the variance in Y-maze working
memory %SA outcomes, and the models for this cognitive out-
comewere not significantly improved by the addition of Aβ1-42 ac-
cumulation (Fig. 7D). This was similar for
CFA short-term memory outcomes, ex-
cept the relationship of m6 to CFA slope
was significantly improved by the addi-
tion of Aβ1-42 accumulation into the lin-
ear model (Fig. 7E). One thing to note is
that the effect of m7, the module up-
stream of working memory and short-
term memory in the Bayesian model
(Fig. 4), on cognitive outcomes was not
improved by the addition of Aβ1-42 accu-
mulation to the linear model, suggesting
a nominal role for how amyloid in-
fluences thesemodule–trait relationships.
Finally, for CFM long-term memory out-
comes, the effect of all except for two
modules (m4, m7) was significantly im-
proved by the addition of Aβ1-42 into
the linearmodel, suggesting that amyloid
may play a more direct role on influenc-
ing the module–trait relationships for
modules associated with long-termmem-
ory (Fig. 7F). Additionally, all except one
of the m5 SCs were significantly im-
proved by the addition of Aβ1-42 into
the linear model (Supplemental Fig. S5A,
B), suggesting that the specific relation-
ship between m5 (and subsequent SCs)
and long-term memory outcomes are in-
fluenced by amyloid accumulation. To
gain a further understanding of the
age-related factors that could drive
these relationships, we recreated linear
models within 6 mo AD-BXDs and 14
mo AD-BXDs (Supplemental Fig. S6).
Interestingly, while the majority of the
variance for working memory and short-
term memory outcomes were observed
within the 6 mo AD-BXD cohort, module
expression explainedmore variance in 14
mo AD-BXDs for long-term memory out-
comes (Supplemental Fig. S6C–E). This
indicates that early-in-life perturbation
ofm7 at 6moor earliermayhave a greater
effect on altering working and short-term
memory cognitive domains, while pertur-
bation of m5 at a later age (14 mo) may
prove more successful to improve the
long-term memory cognitive domain.
Together, these findings suggest a specific
role of the interaction of cortical Aβ1-42
accumulation and module expression on
influencing long-term memory outcomes, while a more indirect
or nominal role of Aβ1-42 accumulation on influencing howmod-
ules affect working memory and short-term memory outcomes.
Cognitively relevant mouse modules replicate in aged
human molecular brain networks
A criticismof usingmousemodels for AD research is thatmanypre-
vious findings in mouse models have failed to translate to human
patients. Therefore, we tested the replication of allmouse coexpres-
sionmodules in human brain data, including those predicted to be
upstreamof variation in cognitive outcomes across ourmouse pop-
ulation. Using a consensus genetic clustering analysis of dorsolat-




Figure 6. Subclustering of the m5 immune module identifies five subclusters with immune function
and QTLs that map to immunologically relevant genetic regions. (A) Composition of m5 based on sub-
cluster (SC) gene membership; for the 848 genes in m5 the subclusters broke out into 291 genes in SC1,
228 genes in SC2, 176 genes in SC3, 108 genes in SC4, and 45 genes in SC5. (B) Spearman correlations
(adj. P<0.05) of m5 and SC1–SC5 to short-term and long-term memory measures. (C,D) The propor-
tion of variance in measures for short-term memory (C) and long-term memory (D) explained by m5
(dark red) and SC1-SC5 (light red) average expression. For B–D SCs are denoted by themost significantly
enriched GO term. (E) Genetic mapping of the first principal component (PC1) as module eigengene for
SC5; Age, sex, and FAD mutation status were used as additive covariates. (F ) Table denoting protein-
coding genes symbols, ensemble IDs, and chromosomal location for each gene within the SC5 QTL
peaks that were also m5 members.
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non-AD) (Mostafavi et al. 2018), weperformed statistical hypergeo-
metric tests to see how well our mouse modules overlapped with
those found in humans. We found that the majority (15/16) of
the cognitively relevant mouse modules were significantly (adj. P
<0.05) conserved in human DL-PFC modules (Fig. 8). The only
nonconservedmodulewasm6 (immune/cell cycle), whichwas sur-
prising since indicators of inflammation are consistently observed
in AD tissue. However, other immune-related modules were con-
served, while the lack of conservation for this module may be
due to its mixture of innate immune re-
sponse genes and cell cycle genes. We
also tested the conservation of molecular
networks generated by a meta-analysis of
multiple brain regions from human aged
and AD tissue (Wan et al. 2020), and
found that all 16 significantly correlated
mouse modules in at least one brain
gene network (Supplemental Fig. S7).
Specifically, all of the significantly corre-
lated mouse modules were conserved in
the DL-PFC molecular networks from
the Accelerating Medicines Partnership-
Alzheimer’s Disease (AMP-AD) consor-
tium meta-analysis molecular networks,
strengthening our findings from the con-
servation with the Mostafavi DL-PFC net-
works. Notably, the two prioritized
modules from our Bayesian analysis (m5
and m7) were both significantly con-
served with several humanmodules asso-
ciated with cognitive function across the
population (Fig. 8; Supplemental Fig.
S7). These results highlight that both
the major molecular networks and ontol-
ogy pathways observed in a genetically
diverse mouse population are also repli-
cated in human cohorts, making our cur-
rent findings prioritizing m5 and m7
relevant to human AD and aging
populations.
Discussion
Systems genetics identifies causal
module–trait relationships in a
population of AD mice that explain
individual differences in cognitive
outcomes
The search for the underlying genetic and
molecular causes of AD cognitive decline
has been the primary goal for identifying
and developing therapeutics for several
decades (Graham et al. 2017). Identifica-
tion of such genetic andmolecular mech-
anisms that influence AD symptoms
using preclinical mouse models has been
criticized because of the poor translatabil-
ity of findings in mouse models to effec-
tively treating human AD (Onos et al.
2016; Drummond and Wisniewski
2017). Modeling the disease in more ge-
netically diverse mice may be one avenue
to improve the construct validity of pre-
clinical models (Hyman and Tanzi 2019;
Neuner et al. 2019a). Using this model,
we were able to leverage transcriptomic and phenotypic informa-
tion from pre- and postsymptomatic mice with and without AD
mutations to identify the molecular networks that are predicted
to directly influence variation in cognitive outcomes across a pop-
ulation.We foundmany sets of coexpressed genes, each represent-
ing the activity of one or more molecular systems, that were
significantly correlated with population-wide differences in cogni-
tion, and explained up to 30% of the variance in cognitive out-







Figure 7. AD-BXD long-term memory module–trait relationships are impacted by the amount of
amyloid accumulation. (A) Average standardized module expression for 5XFAD mice was correlated
to cognitive traits to identify modules that significantly modify cognitive function in the AD-BXD
mouse population. Only the modules that were significantly correlated with cognitive function in the
entire population were tested for significant relationships within the AD-BXD cohort. Modules with
no significant correlation to corresponding cognitive outcome are depicted in white. (B) The proportion
of variance in cognitive outcomes explained by amount of cortical amyloid (quantified by
Aβ1-42-specific sandwich colorimetric ELISA) in AD-BXD mice. (C ) The proportion of variance in
module expression explained by amount of cortical Aβ1-42. (D–F) The proportion of variance in mea-
sures for working memory (D), short-term memory (E), and long-term memory (F) explained by
module expression and amount of cortical Aβ1-42 in AD-BXD mice, using an additive Type 2 ANOVA
model. Variance explained by individual modules significantly positively (blue) and negatively (red) cor-
related to corresponding cognitive trait are in lighter colors, while amount of variance explained by
amyloid as part of the additive linear model is in darker colors. Likelihood-ratio (LRT) tests were per-
formed for each model to test if the addition of cortical Aβ1-42 into the additive model generated a
better fit of linear model. Significant P-values (P<0.05) of LRT tests are denoted by black asterisks, indi-
cating the addition of cortical Aβ1-42 to the model provides a better linear fit than module expression
alone. All modules are annotated by themost significantly enriched GO term (NS GO=no significant GO
enrichment).
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such as those in APOE can explain a considerable proportion of AD
risk, many of the more common AD variants have much smaller
effect-sizes making new gene targets less impactful for translation
to larger populations (Bertram et al. 2007; Genin et al. 2011; Mos-
tafavi et al. 2018). In contrast, the upstream molecular networks
identified here explain larger variances and may have a much larg-
er effect on improving cognitive outcomes on the population lev-
els. The networks consistently explaining the most variance were
enriched for viral and myeloid immune pathway genes (m4, m5,
m6), as well as lipid and coenzyme metabolism pathway genes
(m7, m8). Additionally, genes within these biologically significant
moduleswere found to be primarily expressed in nonneuronal cell-
types such as astrocytes and microglia, suggesting that regulation
of the specific pathways [lipid biosynthesis, IL-1 signaling, interfer-
on (IFN) signaling] within these cell-types contributes most sig-
nificantly to divergent cognitive outcomes across resilient and
susceptible individuals (Zhang et al. 2014). These observations
were further substantiated by our Bayesian modeling of module–
trait relationships in that the only modules directly upstream of
cognitive outcomes were enriched for nonneuronal genes: the as-
trocyte lipid biosynthesis module (m7) for working and short-term
memory, and the microglia viral immune module (m5) for long-
termmemory. This model proposed two cell-type enrichedmolec-
ular networks to prioritize for further investigation, since ourmod-
el predicted that population-wide differences in these networks
have greatest direct impact on regulating cognitive outcomes.
Targeting astrocyte lipid biosynthesis and IL-1 signaling
may promote resilience to working memory and
short-term memory decline
The gene network that our model found to be directly upstream of
working and short-term memory was m7, which was enriched for
“lipid biosynthesis” GO biological pathways. Notably, m7 was ex-
clusively enriched for genes found in astrocytes, specifically, impli-
cating astrocytic lipid biosynthesis as critical for determining
cognitive outcomes. Further IPA analysis also highlighted a nota-
ble m7 gene, Rhoa, that emerged in three of the five top enriched
canonical pathways (Table 1). This gene is of particular interest
because therapeutically targeting RhoA
pathways has been found to be promising
for improving AD and mixed dementia
symptoms, proposing amethod bywhich
targeting m7 could influence AD cogni-
tive outcomes (Herskowitz et al. 2013;
Gentry et al. 2016; Henderson et al.
2019). While these previous studies have
investigated RhoA pathway inhibition in
the context of amyloid and tau pathology
in AD and mixed dementia, these find-
ings could suggest that inhibition of m7
via the RhoA pathway could also improve
cognitive outcomes. Additionally, our
IPA analysis identified other pathways of
interest, such as “IL-1 signaling,” and
“cholesterol biosynthesis.” IL-1 signaling
in astrocytes plays an important role in
promoting inflammation. IL-1 signaling
deficiency has also been demonstrated
to have detrimental effects on hippocam-
pal synaptic plasticity (Moynagh et al.
1994; Ben Menachem-Zidon et al. 2011).
As the IL-1 signaling pathway is also an
indicator of inflammation, the overall
representation of this module could be
for reactive (or A1) astrocytes, which
have been widely described as being induced by inflammatory in-
sult (Zamanian et al. 2012; Anderson et al. 2016; Liddelow et al.
2017). More specifically, reactive astrocytes are thought to be in-
duced by proinflammatory cytokines TNFα, IL-1, and C1Q, which
are highly expressed in microglia in the CNS (Zhang et al. 2014;
Bennett et al. 2016). Two of the three transcripts for these cyto-
kines appear in m5 (Tnf, Il1a), suggesting an interplay between
these twomodules and representative cell-types that directly influ-
ence cognitive resilience. Finally, an indicator of inflammation
that has been characterized in astrocytes and microglia is the for-
mation of lipid droplets within these cells, which synthesizes
with our other finding of additional enrichment of lipid metabo-
lism pathway genes in this module (Farmer et al. 2019;
Marschallinger et al. 2020).
In addition to the interesting proinflammatory pathways, the
“cholesterol biosynthesis” pathway present in m7 suggests an ad-
ditional mechanism by which astrocytes may dictate cognitive
outcomes. Cholesterol biosynthesis has been previously implicat-
ed in AD pathogenesis due to a variety of mechanisms. For exam-
ple, cholesterol influences the relationship between amyloid
precursor protein (APP) and in the production of Aβ, but themech-
anism by which this occurs is still not understood well (Shobab
et al. 2005). In addition, cholesterol biosynthesis is of particular
importance to mature neurons since astrocytes are the primary
cholesterol source for mature neurons in the CNS (Poirier et al.
1993; Pfrieger 2003). A negative association between lipid biosyn-
thesis and cognitive outcomes could indicate a stall or dysfunction
in this process by either depriving neurons of necessary lipids or
over-production within astrocytes. Finally, APOE- the most signifi-
cant risk factor for sporadic AD- is also intimately involved in cho-
lesterolmetabolism. Risk variants inAPOEhave beenhypothesized
to disrupt the ability of APOE to bind cholesterol and therefore
contribute to AD pathogenesis (de Chaves and Narayanaswami
2008; Wood et al. 2014). As the BXD panel contains naturally oc-
curring variation in the Apoe receptor binding domain, this study
mayhave identified the cell-type andpathwaybywhichApoe influ-
ences cognitive resilience (Arboleda-Velasquez et al. 2019; Neuner
et al. 2017, 2019a). Further studies will be conducted to (1) test if
lipid biosynthesis is higher in astrocytes from mice that perform
Figure 8. Mouse modules significantly associated with cognitive outcomes have high degree of con-
servation to human AD modules. Mouse modules significantly correlated to cognitive measures (left,
y-axis) were examined for gene conservation in previously established (Mostafavi et al. 2018) aged/
AD human dorsolateral prefrontal cortex (DL-PFC) modules (top, x-axis). Modules are colored based
on positive (blue) or negative (red) correlation to corresponding mouse (working/short-term/long-term
memory) or human (slope of decline) cognitive measure. Heatmap depicts degree (measured by −log
[adj. P-value]) of overlap (hypergeometric test) between human and mouse modules. Only significant
(adj. P-value <0.05) overlaps are depicted, while nonsignificant overlaps are white. Human modules
were excluded if they did not overlap with at least one mouse module tested above. Mouse modules
are denoted by the most significantly enriched GO term.
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worse on short-term and/or workingmemory cognitive tasks using
pulse-chase experiments (Rambold et al. 2015; Thiele et al. 2019),
and (2) observe if the IL-1 inflammatory signature from this mod-
ule synthesizes with lipids by evaluating lipid droplet formation
within astrocytes fromAD-BXD individuals using BODIPY staining
(Li et al. 2020). These experiments will further our understanding
of the contribution of specific pathways we believe to be involved
in astrocytes that help dictate AD cognitive outcomes.
Fgf2 as a possible regulator of working and short-term
memory outcomes
In this study we leveraged the power of the known genetic compo-
sition of our AD-BXD panel to identify a chromosomal region, and
a protein-coding gene within, that regulates the expression of m7,
themodule directly upstreamof Y-mazeworkingmemory andCFA
short-termmemory outcomes. The nominated gene, Fgf2, showed
a strong negative overall relationship of expressionwith short-term
memory outcomes. The FGF2 protein has a variety of known func-
tions in the CNS, including promoting angiogenesis, neurogene-
sis, and improving symptoms of cognitive aging (Woodbury and
Ikezu 2014). FGF2 is primarily expressed in astrocytes in the adult
brain, but can also be secreted by neurons when damaged to pro-
duce a distress signal to recruit microglia and astrocytes to the
site of damage (Reuss and von Bohlen und Halbach 2003; Noda
et al. 2014). Functionally, FGF2 is known to regulate the prolifera-
tive response to oligodendrocyte precursor cells (OPCs) during
remyelination of axons after acute demyelination injury, suggest-
ing another role of FGF2 signaling in regulating glia-neuron ho-
meostasis (Frost et al. 2003; Magy et al. 2003; Murtie et al. 2005).
Experimentally induced spinal cord and CNS injury has shown
to promote reactive astrogliosis, and these reactive astrocytes
have been previously shown to up-regulate FGF2, suggesting an ad-
ditional involvement of FGF2 in the proliferation and reactivity of
astrocytes to sites of injury and recovery (Fahmy and Moftah
2010). Increased FGF2 (or basic FGF, bFGF) has been observed in re-
active astrocytes and the neurons surrounding amyloid plaques, as
well as its localization to neurofibrillary tangles and cerebrovascu-
lar deposits in AD patient brain tissue (Gomez-Pinilla et al. 1990;
Stopa et al. 1990; Cummings et al. 1993). However, delivery of
FGF2 into the hippocampus of APP mice using AAV2/1 viral con-
struct caused mice to show enhanced long-term potentiation, re-
duced Aβ production, and enhanced neurogenesis, suggesting
FGF2 can act to halt AD pathophysiology (Kiyota et al. 2011).
Together, while our data suggest that more Fgf2 is detrimental to
cognitive performance, other data suggest FGF2 activity is impor-
tant to glial and neuronal response to injury or pathological envi-
ronment. However, characterization of bFGF with AD pathology
suggests it could be part of the reactive astrocyte response to disease
activity. Further work will have to be conducted to determine the
cell-type for which Fgf2 is promoting a negative correlation with
cognitive outcomes, the cellular pathways by which it is acting,
and how it could be detrimental to AD cognitive outcomes.
Targeting viral and adaptive immune pathways to promote
long-term memory resilience
The robust associations of microglia and microglial processes with
improving cognitive outcomes in mice is consistent with genetic
(Lambert et al. 2013; Kunkle et al. 2019) and cellular data (Sosna
et al. 2018; Spangenberg et al. 2019), indicating their relevance
to AD disease activity and cognition (Hong et al. 2016; Kinney
et al. 2018). Surprisingly, when we interrogated our molecular net-
works in search of known AD risk genes enriched in immune
processes, we found that the majority of the sporadic AD
immune-related risk genes were actually present in m4, our im-
mune: myeloid module, and not m5, our immune: virus module.
It was interesting that several high impact sporadic AD genes
(BIN1, TREM2, APOE) were present in a single module (we allowed
discrete assignment of each gene to onemodule in this study), and
also that thismodule did not explain asmuch variance in cognitive
outcomes as the viral immune pathway, with m4 explaining 6.6%
and m5 explaining 10.5% of the variance in long-term memory
(Fig. 3). It could be possible that these m4 LOAD genes and im-
mune: myeloid pathways in m4 have a more indirect effect on
AD cognitive resilience as a molecular system, compared to the vi-
ral immune response pathway.
Given recent evidence that viral immune pathways, including
the type-1 interferon (IFN) pathway, are up-regulated inhumanAD
patients, the viral immune network identified in m5 is an interest-
ing pathway associated with the neuroinflammatory response ob-
served in AD (Taylor et al. 2014). Previous studies using mouse
models of AD have demonstrated that knockout of the type-1
IFN receptor (IFNAR), an important receptor for the viral immune
response, causes reduced amyloid monomer levels, and partial res-
cue of performance on the Morris water maze task at 9 mo of age
(Minter et al. 2016). Recently, conflicting evidence has emerged
about the implications of viral infections, such as the presence of
herpesviruses (HSVs, HHVs) in postmortem brain tissue, with AD
cognitive deficits (Allnutt et al. 2020; Readhead et al. 2018).
While these infections would not be present in the mice used in
this study, since they are raised and aged in a controlled low-
pathogen environment, it is interesting that we still observe activa-
tion of antiviral pathways. Additionally, we found very little over-
lap in m5 genes with genes that drive network activity of cells that
are infected with herpesviruses such as HSV-1 or HHV6A found in
ADpatient brains (Readhead et al. 2018; Drayman et al. 2019). This
suggests that the networks activated by these viruses in human pa-
tients are independent of the viral immune pathways enriched in
m5, and that the m5 network represents an immune response to
nonviral pathological burdens present in the brain, such as Aβ.
This is supportive of our finding that the effect of m5 on long-term
memory outcomes was improved by the addition of cortical Aβ ac-
cumulation in the linear model. However, since the mice used in
this study have not been exposed to a systemic viral challenge, it
could be possible that activating antiviral pathways systemically,
by either HSV infection or poly I:C challenge, could activate other
molecular networks that explainmore variance in long-termmem-
ory outcomes compared to those activated inmice raised in a sterile
environment. More work needs to be done in this field to decipher
a specific interplay between environmental factors (such as viral
exposomes and diet), amyloid and the relevance of their interac-
tion in AD pathogenesis (Dunn et al. 2019).
Along with viral immune pathways being represented in m5,
our subclustering analysis highlighted more distinct immune
pathways that continued to be correlated with long-term memory
measures (Fig. 6; Supplemental Fig. S5). The enriched pathways re-
vealed by these subclusters further supported the importance of vi-
ral immune response pathways (represented in SC1), as well as
indicators of an adaptive immune response (lymphocyte differen-
tiation represented in SC2), and microglial migration (represented
by IL-8 signaling in SC4). These pathways were interesting because
while the importance of viral immune pathways remained, we also
identified other pathways such as the IL-8 signaling pathway that
we would not have identified as the top enriched pathway in the
large m5 module. The IL-8 signaling pathway is interesting in the
context of AD because IL-8 (with the official gene symbol of
Cxcl8) is known to induce microglial migration, and has been pre-
viously found to increase in microglia exposed to amyloid (Lue
et al. 2001; Franciosi et al. 2005). Additionally, IL-8 has been pro-
posed as a biomarker for AD cognitive impairment and cerebrovas-
cular dysfunction when it was found to be up-regulated in blood
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serumof AD and cognitively impaired individuals with cerebrovas-
cular disease compared to noncognitively impaired counterparts
(Zhu et al. 2017). Therefore, enrichment of this pathway could
be a possible indicator of population-wide differences inmicroglial
amyloid migratory response, and differences in cerebrovascular
dysfunction across the AD population. We also may have identi-
fied a measurable marker of resilience and susceptibility to cogni-
tive impairment by identification of this m5 subcluster which we
will test in future studies for validation. Finally, subclustering of
m5 also allowed for genetic mapping of the SC5 eigengene to a re-
gion on chromosome 1 within the AD-BXD population (Fig. 6E,F;
Supplemental Fig. S5C,D). This region was interesting because sev-
eral genes within this locus were also m5 members, and associated
with IFN signaling (Ifi204, Ifi202b), adaptive immune response
(Exo1, Fcrl6), and a glia-specific potassium channel, Kcnj10 (also
known as Kir4.1). The region identified on chromosome 1 is in-
credibly interesting because of its enrichment for these glia and
immune-related genes that were also m5 members, as well as in-
spection of these genes with the Sanger Mouse Genomes database
reveals several coding variants betweenC57BL/6J andDBA/2Jmice
(Keane et al. 2011). Additionally, SC5 was only significantly corre-
lated with long-term memory outcomes, suggesting a specific role
of this SC on integrating overall m5 activity with individual differ-
ences in long-term memory outcomes. Future work will elucidate
how this SC5 molecular network, the chromosome 1 QTL, and
the genes within it possibly control overall m5 activity and long-
term memory outcomes.
Overall, our data and suggest that the specific pathways that
will have the greatest impact on improving cognitive outcomes
are those involved in the microglial viral immune and migratory
response. It is still unclear if this module is representative of the lo-
cal brain immune response by activation of microglia, or if this
pathway is also comprised of infiltrating immune cells that can
also contribute to the neuroinflammatory response in later stages
of AD, which was proposed by the enrichment of lymphocyte dif-
ferentiation genes in m5 SC2 (Heppner et al. 2015). Additionally,
the distinction between peripheral and local neuro-immune re-
sponses in the brain are difficult since microglia and peripheral
macrophages expressmanyof the samemarker genes and proteins.
Although our Bayesian model has found that the neuroinflamma-
tory response is the major contributor to long-term memory resil-
ience in our aging model, further experiments will be done to
distinguish how much of this resilience network is dictated by
peripheral or local innate immune responses. This will include
investigating the role of the systemic immune system, and how in-
creased infiltrating systemic immune cells (CD4+ T cells, B cells, pe-
ripheral macrophages) may play a negative role in cognitive
resilience by evaluating brain gene and protein expression of these
peripheral markers in this mouse population and comparing to
TMEM119+ microglia. Specifically, we hypothesize from these
data that inhibition of the type-1 IFN signaling pathway in more
susceptible mice will promote cognitive resilience by delaying
the neuroinflammatory response that causes cognitive decline in
AD. Additionally, we will further investigate the role of IL-8 as a
possible biomarker of neuroinflammatory activity in susceptible
AD individuals. Finally, we have proposed several gene candidates
fromQTLmapping of the m5 SC5 eigengene that we will examine
as possible targets to promote resilience to AD long-term memory
deficits.
Elucidating the contribution of Aβ accumulation to the
impact of molecular networks on cognitive outcomes
As we have stated previously, AD is classified by progressive and
severe memory decline, as well as the pathological presence of
beta-amyloid (Aβ) plaques and neurofibrillary tau tangles (Selkoe
1991). It is still widely debated if amyloid is directly involved in de-
termining AD cognitive trajectories, or if it ismore of associated pa-
thology with limited involvement in cognitive decline (Murphy
and LeVine 2010). We previously found in our AD-BXD popula-
tion that while cortical Aβ1-42 levels were variable across genetic
backgrounds (especially at 14 mo), this variability did not directly
correlate with cognitive function (Neuner et al. 2019a). Here, we
found that many of our identified module–trait relationships
were strengthened when we isolated and tested these relationships
in the AD-BXD population (Supplemental Table S4; Fig. 7A), indi-
cating the presence of FADmutations is necessary for these molec-
ular networks to influence cognitive outcomes. Using additional
linear modeling, we tested the effects of cortical Aβ1-42 accumula-
tion onmodule expression, and if it could improve the influence of
module expression on cognitive outcomes. Our results indicated a
domain-specific effect that workingmemory and short-termmem-
ory were primarily influenced by module expression, and largely
independent of individual differences in amyloid burden (Fig.
7D,E). However, for long-term memory cortical Aβ1-42 accumula-
tion improved the effect of module expression on memory out-
comes, indicating an indirect role of amyloid on cognition
through influencing module expression (Fig. 7F; Supplemental
Fig. S5B). Therefore, we hypothesize that the role of Aβ on AD cog-
nitive trajectories could be more complex than initially anticipat-
ed, and dependent on the cognitive domain and molecular
pathway. It is possible that more module variance could be ex-
plained if we hadmeasured and compared hippocampal Aβ1-42 ac-
cumulation to gene expression changes instead of cortical Aβ1-42,
and are working to test this difference in future studies using
Aβ1-42 staining of fixed hemibrains from the samemice investigat-
ed here. Further studies will also test this model to see how pertur-
bation of certain molecular networks influences cognitive
outcomes, and if these networks will alter amyloid accumulation
or if secondary amyloid targeting is also needed to havemaximum
effect, especially for long-term memory outcomes.
Advantages of diverse mice for defining the genetic origins
of resilience
In this study, we were able to leverage previously generated tran-
scriptome and phenotype information from a population of genet-
ically diverse mice to identify the molecular networks that directly
influence population-wide differences in cognitive outcomes. An
advantage of using a genetic reference panel such as the BXDs is
that we could leverage the well-defined genetics of this population
to perform genetic mapping that anchored many of our module–
trait relationships.
In addition to identifying immune and lipid metabolism
pathways, as well as the Fgf2 gene, as being possible direct regula-
tors of AD cognitive outcomes, this study also identified neuronal
and synaptic modules that were correlated to short-term memory
outcomes (see Fig. 3A). We wanted to highlight these neuronal
pathways in particular because recent studies using AD patient
brain tissue have found that changes in dendritic spine morpholo-
gy can indicate resilience to AD cognitive decline (Boros et al. 2017,
2019). Further studies will test the importance of neuronal
pathways in providing AD resilience, especially in the context of
susceptible compared to resilient microglia or astrocyte environ-
ments, since targeting neuronal pathways have also been suggest-
ed to be desirable for therapeutic intervention in AD (Gentry et al.
2016; Henderson et al. 2019). Future work overlaying gene expres-
sion from mice that receive such interventions will also highlight
how these molecular networks interact with each other when a
specific module or target is perturbed. Finally, analysis of gene ex-
pression from this model system and comparison to human brain
networks has nominated conserved molecular systems that are
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relevant to diverse AD cognitive outcomes. The identification
of these relevant molecular systems will lead to a better
understanding of preclinical models of human AD, which will al-




All mouse experiments occurred at University of Tennessee Health
Science Center and were carried out in accordance with the princi-
pals of the Basel Declaration and standards of the Association for
the Assessment and Accreditation of Laboratory Animal Care
(AAALAC), as well as the recommendations of the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals. The protocol was approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of Tennessee
Health Science Center.
Animals
All data used in this study are from a mouse model of human AD,
the AD-BXD panel, which were previously described (Neuner et
al. 2019a). Briefly, female B6 mice hemizygous for the 5XFAD
transgene (B6.Cg-Tg(APPSweF1LonPSEN1*M146L*L286V)6799Vas/
Mmjax, Stock No. #24848-JAX) were mated to males from the
BXD genetic reference panel (Williams et al. 2001; Peirce et al.
2004). One generation of breeding B6-5XFAD damswith BXD sires
results in a set of 26 isogenic F1 AD-BXD strains that either harbor
the 5XFAD transgene or are nontransgenic (Ntg)-BXD littermate
controls. Male and female AD-BXD mice were group housed as a
mix of 5XFAD and nontransgenic same-sex littermates and main-
tained on a 12 h light–dark cycle.
Y-maze
Behavioral testing to assessmice for workingmemory functionwas
performed as previously described (Neuner et al. 2019a). In brief,
mice were habituated to transport and to the testing room for 3 d
prior to testing. The y-maze test of spontaneous alternation was
performed for 8 min using a clear acrylic Y-shaped maze with
arms that were 2 inch wide ×12 inch long×12 inch high (Oakley
et al. 2006; Neuner et al. 2019a). The maze was placed on a table
in a dimly lit room and spatial cues were displayed onwalls around
the table. Mice were placed in a randomized start arm and video
tracking software was used to monitor arm entries (ANY-maze,
Stoelting Co.). An arm entry was called when the mouse’s entire
body, including the two back feet, entered the arm. The sequence
and total number of arms enteredwas recorded, and the percentage
of successful alternations was calculated as follows: number of al-
ternations/maximum possible alternations (total number of arms
entered−2) × 100. Mice were evaluated for performance on this
task longitudinally every 2 mo until their specified harvest age (6
mo or 14 mo). AD-BXD and Ntg-BXD strain/age/sex specific group
averages were generated for further downstream analyses.
Contextual fear conditioning
After 3 d of habituation to transport and to the testing room, mice
underwent contextual fear conditioning (CFC) as previously de-
scribed (Neuner et al. 2015). On the first day of CFC training,
micewere placed in a chamber and four 0.9mA1 sec (s) foot shocks
were delivered after a baseline period. Over the period of 700 sec
four foot shocks were delivered, and the postshock intervals were
defined as the 40 sec following the offset of each foot shock. The
slope of the line formed when the percentage of time spent freez-
ing following each shockwas calculated as a function of each inter-
val was used as ameasure for contextual fear acquisition (CFA), and
short-term memory. Twenty-four hours after training, mice were
placed back into the training chamber and the percentage of
time spent freezing throughout the entire 600 sec test was mea-
sured as an index of contextual fearmemory (CFM), and long-term
memory. AD-BXD and Ntg-BXD strain/age/sex specific group aver-
ages were generated for further downstream analyses.
RNA sequencing
Initial RNA sequencing (RNA-seq) of hippocampus from the
AD-BXD panel [6 mo, n= 71 (47 females/24 males) and 14 mo,
n =86 (45 females/41 males)], and Ntg-BXD counterparts [6 mo,
n= 31 (17 females/14 males) and 14 mo, n=33 (17 females/16
males)] has been previously reported ((Neuner et al. 2019a) GEO
accession number GSE101144; (Neuner et al. 2019b) GEO acces-
sion number GSE119215). Here, we expand upon this data set to
include RNA sequencing data from an additional 71 Ntg-BXD
mice, 27 of which were 6 mo of age (22 females/5 males) and 44
of which were 14 mo of age (28 females/16 males, GEO accession
number GSE119408). RNA-seq was performed as previously de-
scribed (Neuner et al. 2019a). Briefly, all samples were isolated us-
ing the Qiagen RNeasy Mini kit, libraries were prepared using
Truseq Stranded mRNA Sample Preparation Kit (Illumina Inc.),
and sequenced by 75 bp sequencing on an Illumina HiSeq2500.
Because sequencing was performed on mice harboring alleles for
C57BL/6J (B6) and DBA2/J (D2), the GBRS/EMASE pipeline
(Raghupathy et al. 2018) developed by the Churchill group at
The Jackson Laboratory was used in order to align reads to the cor-
rect allele, allowing for quantification of both total reads for a gene
and reads assigned to the B6 or D2 allele. To account for the expres-
sion of the 5XFAD transgene, RNA-seq reads were additionally
aligned to the mutated human APP and PSEN1 sequences. Genes
were filtered to require an average of at least 1 transcript permillion
(TPM) in 50% of samples. RNA data was batch corrected using
ComBat (Johnson et al. 2007; Leek et al. 2012), and biological rep-
licates were averaged together for downstream analyses. During
batch correction, two samples (S3 and S285) were included in
data upload, but dropped in final analyses as outliers before strain
averaging. For final downstream analysis, individual samples be-
longing to the same BXD strain/sex/age/mutation carrier group
were averaged to generate 156 distinct groups.
Formation of gene coexpression modules
Consensus clustering was used on gene transcripts per million
(TPM) values from the RNA-seq results using a novel algorithm
(Gaiteri et al. 2015) to identify groups of coexpressed genes or
“modules” that represented genes that were commonly regulated
together across the examined mouse population. The consensus
clustering algorithm, SpeakEasy, was used to identify 31 discrete
transcriptional modules of coexpressed genes that ranged in size
between four to 1419 gene members. Twenty eight of the 31 mod-
ules containedmore than 29 genemembers, and could be assigned
for >99% of the genes analyzed for coexpression. Therefore, three
modules with fewer than 30 genes were excluded from down-
stream analysis, and contained <1% of total genes used for coex-
pression. This is consistent with previous methods for exclusion
of modules with small membership (Mostafavi et al. 2018).
Module functional enrichment
Gene Ontology (GO) functional enrichment analysis was per-
formed on the genes within each module using the clusterprofiler
package in R. GO categories with a hypergeometric enrichment ad-
justed P<0.05 (adjusted for multiple comparisons using the
Benjamini Hochberg correction) were considered to be signifi-
cantly enriched within that corresponding module. Modules
were named using their corresponding number as well as the top
most significantly enriched GO category.
Module cell-type enrichment
Genes in each module were evaluated for cell-type enrichment
from a previous study using a mineable set of genes obtained
from RNA-seq of sorted cells from the adult mouse cerebral cortex
(Zhang et al. 2014). The cell-type assignment for each gene was de-
termined by identifying the max fragments per kilobase of tran-
script per million mapped reads (FPKM) for each gene in one of
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the seven cell populations included in the RNA-seq data set. Each
module was evaluated for enrichment using hypergeometric tests
to examine the overlap of module genes for genes in each cell
type. The list of 12,978 genes downloaded from brainrnaseq.org
was used as the background set, andmodule genes that had at least
one cell-type assignment were used. A Benjamini Hochberg correc-
tion for multiple comparisons was performed using the p.adjust()
function in R to obtain adjusted P-values of significant overlap
from these tests.
Identification of module–trait relationships
Pairwise correlation analysis was used to test the relationships be-
tween module expression and cognitive measures. First, the stan-
dardized average expression for each module was calculated
across all 156 strain/sex/age/mutation carrier group measures (set-
ting average=0, standard deviation=1). To test the relationship of
modules to cognition,we performed Spearman correlation analysis
to identify the specific molecular networks that significantly relat-
ed to individual differences in cognitive outcomes. Using the
previously reported (Neuner et al. 2019a) cognitive measures for
each corresponding strain/sex/age/mutation carrier grouping,
Spearman correlations for module average expression to measures
for working memory (assessed using the Y-maze task), short-term
memory, and long-term memory (assessed using CFC) were calcu-
lated. We chose the Spearman correlation approach over Pearson
correlations becausewhenwe tested for normality of cognitive out-
comes and module expression across the population, while cogni-
tive outcomes were normally distributed (Supplemental Fig. S4),
module expression was not (Supplemental Table S9). Modules
that were significantly correlated (Benjamini Hochberg adjusted
P<0.05) with at least one of these three traits were selected for in-
clusion of downstream Bayesian direct acyclic graph analysis.
ANOVA analysis of module expression on binary-coded
traits
Possible sources of variation in module expression were evaluated
using a Type 2 ANOVA as a function of mutation carrier + age+ sex
(where mutation carrier denotes the presence/absence of the
5XFAD transgene) (Supplemental Fig. S1; Supplemental Table
S3). All P-values were adjusted using the Benjamini Hochberg cor-
rection for multiple comparisons.
Calculation of variance explained
Effect size was calculated by generating a linearmodel using the lm
() function in R, where formula=dependent∼ independent. In this
formula, dependent variables corresponded to the cognitive mea-
sure for working memory (percent spontaneous alternations),
short-term memory (CFA slope), or long-term memory (percent
freezing during CFC testing, CFM), and the independent variable
was the standardized average expression for a specific module. A
Type 2 ANOVAwas performed, and the variance explained was ob-
tained by taking the sum of squares for module expression and di-
viding by the total sum of squares for each model, which also
corresponded to the multiple R2 for each linear model. This analy-
sis was performed for eachmodule that was significantly correlated
toworking, short-term, and long-termmemorymeasures. To deter-
mine the variance explained in AD-BXD individuals when amount
of amyloid was added into the model, we first used a Type 3
ANOVA to test for significant interactions betweenmodule expres-
sion and amyloid amount. After identifying only one significant
module*amyloid interaction (module 4*amyloid for Y-maze %
SA), we continued with an additive Type 2 ANOVA model. For
thismodel, the same protocol was used as before in which variance
explained was calculated using individual sum of squares for each
independent variable divided by the total sum of squares (includ-
ing residual sum of squares). Likelihood-ratio (LRT) tests were per-
formed to determine if the addition of cortical Aβ1-42 into the
linear model significantly improved the fit. In this calculation,
model 1: cognitive outcome∼module expression was tested
against model 2: cognitive outcome∼module expression+ cortical
Aβ1-42 ELISA to obtain a P-value which reflected if the twomodels
were significantly different from each other. LRT tests with P<0.05
were interpreted to have a better fit with the addition of cortical
Aβ1-42 than with module expression alone. Results of ANOVA
analyses and LRT tests are depicted in Supplemental Table S8.
Module-trait network
Themodule-trait network was constructed using the predefined re-
lationships of modules that significantly correlated with at least
one cognitive outcome, as well as genetic information provided
by quantitative trait locus (QTL) mapping of module eigengenes.
This module-trait network of mixed node times illustrated condi-
tional dependencies among all variables (module expression, cog-
nitive measures), and utilized genomic priors (genetic regions
associated withmodule eigengenes) to help determine the orienta-
tion of edges in the resulting network (Tasaki et al. 2015;Mostafavi
et al. 2018).
Module QTL mapping
Quantitative trait locus (QTL) mapping was performed using the
eigengene for each module significantly correlated with cognitive
outcomes. Genotypes for the BXD strains used in this study were
obtained from GeneNetwork.org (Mulligan et al. 2017), and mod-
ule eigengenes (ME) were generated by calculating the first princi-
pal component (PC1) of module expression. The BXD genotypes
and module eigengenes were used for downstream QTL mapping
in r/qtl (Broman et al. 2003). ANOVA analyses of module expres-
sion (Supplemental Fig. S1) were used to establish age sex, and/or
genotype as additive covariates for each module. Covariates were
used as additive, and 1000 permutations were used to determine
statistical significance. Results of all QTL mapping is depicted in
Supplemental Table S4.
Ingenuity pathway analysis
Ingenuity Pathway Analysis (IPA) was performed to complement
the initial GO enrichment for gene coexpression modules.
Specifically, the top enriched canonical pathways (by enrichment
P-value) in the IPA Canonical Pathway Analysis report were ana-
lyzed to gain a more specific understanding of enriched pathways
in modules.
Enzyme-linked immunosorbent assay (ELISA)
Data for beta-amyloid 1-42 (Aβ1-42) quantification was used from
ELISA arrays performed and described in our previously published
study (Neuner et al. 2019a). Briefly, Aβ1-42 levels were quantified
from sections of temporal cortex [6 mo n=72 mice (46 female/46
male) across 22 AD-BXD strains, 14 mo n =82 mice (43 female/33
male) across 21 AD-BXD strains]. Tissue was homogenized in 1×
PBS+1% Triton X-100 using the TissueLyser II system (QIAGEN)
and sonicated 2 ×10 sec on low power. Protein concentration
was determined using a NanoDrop 2000 UV-Vis Spectrophotome-
ter (ThermoScientific). Brain homogenates (10 mg/mL) were ex-
tracted in a final concentration of 5 M GuHCl overnight at 4°C.
Samples were then diluted appropriately and run in duplicate on
Aβ1-42-specific sandwich colorimetric ELISAs according to the
manufacturer’s protocol (Cat# 298-92401,WakoChemicals). Opti-
cal densities at 450 nm were read on a Biotek plate reader (BioTek)
and Aβ1-42 concentration was determined by comparison with
Aβ1-42 standard curves. Only readings in the linear range of the
standard curvewere included in analysis. Duplicates were averaged
to determine concentration of Aβ1-42 in each sample. Finally,
Aβ1-42 concentrations were normalized to total protein concentra-
tion and are reported as nanograms of Aβ1-42 per milligrams of to-
tal protein.
Mouse-to-human module comparisons
Gene coexpression modules formed by using SpeakEasy clustering
on bulk RNA-seq from human dorsolateral prefrontal cortex
(DL-PFC) tissue were obtained from a previously published
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Religious Orders Study and Memory and Aging Project (ROSMAP)
data set (Mostafavi et al. 2018), as well as coexpression modules
from multiple human brain regions from the Accelerating
Medicine Partnership- Alzheimer’s Disease (AMP-AD) consortium
(Wan et al. 2020). In the Mostafavi study, there were 47 modules
formed with at least 20 gene members, and modules were related
to human cognitive outcomes using a correlation approach similar
to what was performed in this current study. In the AMP-AD study,
there were 30 primary modules generated across seven brain re-
gions and three studies compiled from a meta-analysis of human
aged and AD brains. Human genes from these modules were con-
verted to orthologous mouse genes using the biomaRt() package
in R. Hypergeometric tests were used between each human and
mouse module to examine the degree of conservation between
the two species. The background gene list used was the total num-
ber of unique genes that could be found in any human or mouse
module. The Benjamini-Hochberg correction for multiple compar-
isonswas performed to obtain adjusted P-value using the p.adjust()
function in R. All human and mouse modules that passed the pre-
liminary filtering step (mouse modules >29 genes, Mostafavi hu-
man modules >20 genes, all AMP-AD modules) were examined
for this analysis.
Statistical analysis and software
R software version 3.6.3 was used for data analysis. Code for
SpeakEasy clustering was obtained from an online repository
(https://www.cs.rpi.edu/~szymansk/SpeakEasy/index.html)
(Gaiteri et al. 2015), and run in Matlab version 2018a. Statistical
tests included ANOVA, hypergeometric tests for overlap,
Spearman correlations, and Benjamini Hochberg corrections for
multiple testing. All scripts used for these analyses have been post-
ed for open access to GitHub (Heuer_2020) and data files on
Synapse.org (10.7303/syn17016211). Code for Bayesian modeling
was obtained from an online repository at Synapse.org (10.7303/
syn2910187) (Tasaki et al. 2015).
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